{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:25:12Z","timestamp":1788024312692,"version":"build-2784847793"},"reference-count":66,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Juvenile psoriatic arthritis (JPsA) accounts for 1\u20137% of all cases of juvenile idiopathic arthritis (JIA) and its definition has been a matter of controversy among pediatric rheumatologists for many years. The traditional attribution of JPsA to the spondyloarthropathy group was challenged in the early 1990s, whereas the recent demonstrations of its heterogenous nature have led to questions about its identification as a distinct category in JIA classification. It has been shown that children with the phenotype of JPsA can be divided in two subgroups, one presenting with the features of early-onset ANA-positive JIA, and another that belongs to the spectrum of spondyloarthropathies. The few studies that have compared the clinical characteristics and genetic determinants of JPsA with those of the other JIA categories have obtained contrasting findings. The debate on the categorization of JPsA as a distinct entity within JIA classification is still ongoing and has prompted the revision of its current classification.<\/jats:p>","DOI":"10.3390\/jcm12010367","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T02:05:53Z","timestamp":1672711553000},"page":"367","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-9055","authenticated-orcid":false,"given":"Roberta","family":"Naddei","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Mediche Traslazionali, Universit\u00e0 degli Studi di Napoli Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-3442","authenticated-orcid":false,"given":"Ana","family":"Rebollo-Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Burrone","sequence":"additional","affiliation":[{"name":"Dipartimento di Pediatria, Ospedale dei Bambini \u201cVittore Buzzi\u201d, Universit\u00e0 degli Studi di Milano, 20154 Milan, Italy"},{"name":"Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Universit\u00e0 degli Studi di Genova, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-4134","authenticated-orcid":false,"given":"Valentina","family":"Natoli","sequence":"additional","affiliation":[{"name":"Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Universit\u00e0 degli Studi di Genova, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rosina","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Consolaro","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"},{"name":"Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Universit\u00e0 degli Studi di Genova, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9658-0385","authenticated-orcid":false,"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Universit\u00e0 degli Studi di Genova, 16132 Genoa, Italy"},{"name":"Direzione Scientifica, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"ref_4","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","article-title":"Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: An observational cohort study","volume":"3","author":"Consolaro","year":"2019","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_6","first-page":"S55","article-title":"Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis?","volume":"12","author":"Petty","year":"1994","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_7","first-page":"1900","article-title":"Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis?","volume":"30","author":"Martini","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3899\/jrheum.090510","article-title":"Juvenile psoriatic arthritis: Bathwater or baby?","volume":"36","author":"Nigrovic","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_9","first-page":"S40","article-title":"The conundrum of juvenile psoriatic arthritis","volume":"33","author":"Ravelli","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108396","DOI":"10.1016\/j.clim.2020.108396","article-title":"Psoriatic arthritis in childhood: A commentary on the controversy","volume":"214","author":"Stoll","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: First steps, Pediatric Rheumatology International Trials Organization International Consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.21.3.253","article-title":"Diagnosis of \u201cprobable\u201d Still\u2019s disease and its outcome","volume":"21","author":"Ansell","year":"1962","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780160222","article-title":"Psoriatic arthritis in a child","volume":"16","author":"Angevine","year":"1973","journal-title":"Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_15","first-page":"195","article-title":"Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of the Arthritis Foundation","volume":"20","author":"Brewer","year":"1977","journal-title":"Arthritis Rheum."},{"key":"ref_16","unstructured":"Munthe, E. (1978). Special Meeting on: Nomenclature and classification of arthritis in children. The Care of Rheumatic Children, EULAR Publisher."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0307-742X(21)00179-X","article-title":"2\u2014Psoriatic arthritis in childhood","volume":"2","author":"Lambert","year":"1976","journal-title":"Clin. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(82)80747-6","article-title":"Juvenile psoriatic arthritis\u2014An analysis of 60 cases","volume":"100","author":"Shore","year":"1982","journal-title":"J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/anr.1780320810","article-title":"Psoriatic arthritis in children","volume":"32","author":"Southwood","year":"1989","journal-title":"Arthritis Rheum."},{"key":"ref_20","first-page":"166","article-title":"Juvenile psoriatic arthritis: Followup and evaluation of diagnostic criteria","volume":"23","author":"Roberton","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_21","first-page":"1566","article-title":"Proposal for the development of classification criteria for idiopathic arthritides of childhood","volume":"22","author":"Fink","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_22","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Petty, R.E., Laxer, R., Lindsley, C., and Wedderburn, L. (2015). Juvenile psoriatic arthritis. Textbook of Pediatric Rheumatology, Elsevier. [7th ed.].","DOI":"10.1016\/B978-0-323-24145-8.00015-6"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/art.22173","article-title":"Patients with juvenile psoriatic arthritis comprise two distinct populations","volume":"54","author":"Stoll","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3899\/jrheum.160717","article-title":"The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes","volume":"44","author":"Zisman","year":"2017","journal-title":"J. Rheumatol."},{"key":"ref_26","first-page":"1531","article-title":"Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis","volume":"29","author":"Huemer","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_27","first-page":"377","article-title":"Subpopulations within juvenile psoriatic arthritis: A review of the literature","volume":"13","author":"Stoll","year":"2006","journal-title":"Clin. Dev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00256-008-0537-1","article-title":"MRI findings of juvenile psoriatic arthritis","volume":"37","author":"Lee","year":"2008","journal-title":"Skelet. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-015-0003-2","article-title":"Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: Histology of an established clinical entity","volume":"13","author":"Tuttle","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3899\/jrheum.210755","article-title":"Occurrence and risk factors of uveitis in juvenile psoriatic arthritis: Data from a population-based nationwide study in Germany","volume":"49","author":"Rothaus","year":"2022","journal-title":"J. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/rheumatology\/32.9.836","article-title":"HLA and juvenile psoriatic arthritis","volume":"32","author":"Ansell","year":"1993","journal-title":"Rheumatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.23240","article-title":"Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis","volume":"59","author":"Toll","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3899\/jrheum.160173","article-title":"Unraveling the phenotypic variability of juvenile idiopathic arthritis across races or geographic areas\u2014Key to understanding etiology and genetic factors?","volume":"43","author":"Consolaro","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar3235","article-title":"Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis","volume":"13","author":"Hinks","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.23604","article-title":"Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis","volume":"58","author":"Day","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3899\/jrheum.080543","article-title":"Juvenile psoriatic arthritis: Longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis","volume":"36","author":"Lien","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/annrheumdis-2016-210025","article-title":"Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases","volume":"76","author":"Hinks","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.42037","article-title":"2021 American College of Rheumatology Guideline for the treatment of juvenile idiopathic arthritis: Therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis","volume":"74","author":"Onel","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40884","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: Therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis","volume":"71","author":"Ringold","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13075-019-1916-9","article-title":"Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial","volume":"21","author":"Foeldvari","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3899\/jrheum.150430","article-title":"Two-year efficacy and safety of etanercept in pediatric patients with extended oligoarthritis, enthesitis-related arthritis, or psoriatic arthritis","volume":"43","author":"Constantin","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2012-203046","article-title":"Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study","volume":"73","author":"Horneff","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.40884","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Ringold","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Brunner, H.I., Foeldvari, I., Alexeeva, E., Ayaz, N.A., Calvo Penades, I., Kasapcopur, O., Chasnyk, V.G., Hufnagel, M., \u017buber, Z., and Schulert, G. (2022). Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: A randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. Ann. Rheum. Dis.","DOI":"10.1136\/ard-2022-222849"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40272-022-00533-y","article-title":"Intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis and subcutaneous ustekinumab in patients with juvenile psoriatic arthritis: Extrapolation of data from studies in adults and adjacent pediatric populations","volume":"24","author":"Leu","year":"2022","journal-title":"Paediatr. Drugs"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/bjd.19018","article-title":"Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (\u22656 to <12 years of age): Efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study","volume":"183","author":"Philipp","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","article-title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study","volume":"73","author":"Landells","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/2475530318799072","article-title":"Pediatric psoriatic arthritis: A population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities","volume":"3","author":"Brandon","year":"2018","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/kex323","article-title":"Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort","volume":"56","author":"Tillett","year":"2017","journal-title":"Rheumatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e000304","DOI":"10.1136\/rmdopen-2016-000304","article-title":"Juvenile idiopathic arthritis in adulthood: Fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage","volume":"2","author":"Martins","year":"2016","journal-title":"RMD Open"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Silvy, F., Bertin, D., Bardin, N., Auger, I., Guzian, M.C., Mattei, J.P., Guis, S., Roudier, J., and Balandraud, N. (2015). Antinuclear antibodies in patients with psoriatic arthritis treated or not with biologics. PLoS One, 10.","DOI":"10.1371\/journal.pone.0134218"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/annrheumdis-2012-201388","article-title":"It is time to rethink juvenile idiopathic arthritis classification and nomenclature","volume":"71","author":"Martini","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_58","first-page":"582","article-title":"Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis","volume":"29","author":"Stoll","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12969-017-0145-5","article-title":"Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis\u2014An eight-year follow-up study","volume":"15","author":"Ekelund","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3899\/jrheum.180131","article-title":"Juvenile psoriatic arthritis: A report from the GRAPPA 2017 annual meeting","volume":"94","author":"Zisman","year":"2018","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3899\/jrheum.170598","article-title":"Adiposity in juvenile psoriatic arthritis","volume":"45","author":"Samad","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/03009742.2014.999351","article-title":"Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis","volume":"44","author":"Schenck","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: A population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/art.30076","article-title":"Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis","volume":"63","author":"Ravelli","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3899\/jrheum.080674","article-title":"Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: How different are they?","volume":"36","author":"Butbul","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-11-11","article-title":"Juvenile Psoriatic Arthritis (JPsA): Juvenile arthritis with psoriasis?","volume":"11","author":"Tyrrell","year":"2013","journal-title":"Pediatr. Rheumatol. Online J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/1\/367\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:56:52Z","timestamp":1760119012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/1\/367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12010367"],"URL":"https:\/\/doi.org\/10.3390\/jcm12010367","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}